SABCS® Daily Highlights for Thursday, December 7


Estimated Read Time:

3 minutes

By Kate Lathrop, MD
SABCS® Program Director,
SABCS® Executive and Program Planning Committees

Kate Lathrop, MD
Kate Lathrop, MD

Welcome to another great day of science and collaboration at the 2023 SABCS®. If you haven’t had a chance yet to check out our updated Poster Spotlight Sessions, today would be a great day for it. There is a block in the morning, from 7:00 a.m. to 8:00 a.m. CT, and an afternoon block from 5:30 p.m. to 6:30 p.m. CT. Check the meeting site for locations, topics, and areas of research that interest you. Each spotlight session will include brief presentations by the authors and discussants to put the research into context and an opportunity for Q&A with the authors.

Today’s General Session 2 is filled with notable, cutting-edge research, including:

  • GS02-01–Randomized phase 3 study of datopotamab deruxtecan vs chemotherapy for patients with inoperable or metastatic hormone receptor-positive, HER2- breast cancer: efficacy, safety, and biomarker results from TROPION-Breast01.

This session is presented by Aditya Bardia, MD, MPH, Massachusetts General Hospital Cancer Center.

  • GS02-10–Effects of a structured and individualized exercise program on fatigue and health-related quality of life in patients with metastatic breast cancer: the multinational randomized controlled PREFERABLE-EFFECT study

The session is presented by Anne M. May, PhD, University Medical Center Utrecht, Netherlands.

  • GS02-11–Fertility preservation and assisted reproductive technologies (ART) in breast cancer (BC) patients (pts) interrupting endocrine therapy (ET) to attempt pregnancy

The session is presented by Hatem A. Azim, Jr., MD, PhD, School of Medicine, Monterrey Institute of Technology, Mexico.

Today’s General Session starts at 8:15 a.m. CT in Hall 1 with moderators Antoinette R. Tan, MD, MHSc, Levine Cancer Institute, Atrium Health; and Roshni Rao, MD, FACS, Columbia University Irving Medical Center.

Kornelia Polyak, MD, PhD, FAACR, is the recipient of the 2023 AACR Distinguished Lectureship in Breast Cancer Research, supported by Aflac Inc. This award was established to recognize outstanding science that has inspired, or has the potential to inspire, new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer. The lecture will be at 1:00 p.m. CT in the Stars at Night Ballroom 1–2.

Clinical Controversies with moderator Lisa A. Carey, MD, ScM, FASCO, UNC Lineberger Comprehensive Cancer Center, will highlight topics of debate among breast cancer clinicians, including staging axilla, treating small triple-negative breast cancer, and managing treatment for postmenopausal patients. The session promises some spirited discussion and is set for 2:00 p.m. CT in the Stars at Night Ballroom 3–4.

Round out your afternoon with the Education Session Block #3, which includes the session Inflammatory Breast Cancer: Clinical Challenges, Evolving Concepts and Novel Treatments (People’s Choice) in Hemisfair Ballroom 1–2 from 3:10 p.m. to 5:00 p.m. CT. Moderator Filipa Lynce, MD, Dana-Farber Cancer Institute, will guide presenters and panelists through discussions on inflammatory breast cancer, surgical approaches, and radiation therapy. 

Just a few of the exciting sessions happening today—enjoy another inspiring day of education and connection!

And be sure to check each day for more meeting highlights, program previews, session recaps, and all the news from the 2023 SABCS®.